Cargando…

FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis

Cholestasis impairs liver regeneration following partial liver resection (PHx). Bile acid receptor farnesoid X-receptor (FXR) is a key mediator of liver regeneration. The effects of FXR agonist obeticholic acid (OCA) on liver (re)growth were therefore studied in cholestatic rats. Animals underwent s...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Golen, Rowan F., Olthof, Pim B., Lionarons, Daniël A., Reiniers, Megan J., Alles, Lindy K., Uz, Zehra, de Haan, Lianne, Ergin, Bulent, de Waart, Dirk R., Maas, Adrie, Verheij, Joanne, Jansen, Peter L., Damink, Steven W. Olde, Schaap, Frank G., van Gulik, Thomas M., Heger, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224438/ https://www.ncbi.nlm.nih.gov/pubmed/30409980 http://dx.doi.org/10.1038/s41598-018-33070-1

Ejemplares similares

Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid
por: de Haan, Lianne R., et al.
Publicado: (2021)

IL-23 and IL-17A are not involved in hepatic/ischemia reperfusion injury in mouse and man
por: Olthof, Pim B., et al.
Publicado: (2015)

Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport
por: Lionarons, Daniël A., et al.
Publicado: (2016)

Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
por: Lin, Chuangzhen, et al.
Publicado: (2022)

The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma
por: Di Matteo, S., et al.
Publicado: (2019)

FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
por: Verbeke, Len, et al.
Publicado: (2016)

Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders
por: Appelman, Monique D., et al.
Publicado: (2021)

Preparation and Practical Applications of 2′,7′-Dichlorodihydrofluorescein in Redox Assays
por: Reiniers, Megan J., et al.
Publicado: (2017)

Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models
por: Zhang, Yuanyuan, et al.
Publicado: (2017)

FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver disease
por: Koelfat, Kiran V.K., et al.
Publicado: (2017)

Analysis and Optimization of Conditions for the Use of 2′,7′-Dichlorofluorescein Diacetate in Cultured Hepatocytes
por: Reiniers, Megan J., et al.
Publicado: (2021)

Obeticholic Acid Protects against Gestational Cholestasis-Induced Fetal Intrauterine Growth Restriction in Mice
por: Chen, Wei, et al.
Publicado: (2019)

The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway
por: Attia, Yasmeen M., et al.
Publicado: (2017)

The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease
por: Zhang, Dan-Ying, et al.
Publicado: (2019)

Influence of cholestasis on portal vein embolization-induced hypertrophy of the future liver remnant
por: Chang, Xinwei, et al.
Publicado: (2023)

BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination
por: Jung, Hyunkyung, et al.
Publicado: (2020)

Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers
por: Wiggers, Jimme K., et al.
Publicado: (2017)

Experimental Conditions That Influence the Utility of 2′7′-Dichlorodihydrofluorescein Diacetate (DCFH(2)-DA) as a Fluorogenic Biosensor for Mitochondrial Redox Status
por: de Haan, Lianne R., et al.
Publicado: (2022)

Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
por: Gomez-Ospina, Natalia, et al.
Publicado: (2016)

Stat3 role in the protective effect of FXR Agonist in parenteral nutrition-associated cholestasis
por: Ghosh, Swati, et al.
Publicado: (2023)

Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR
por: Dong, Bin, et al.
Publicado: (2019)

Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy
por: Weijer, Ruud, et al.
Publicado: (2015)

Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling
por: Xiao, Yongtao, et al.
Publicado: (2018)

Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice
por: Wei, Shizhang, et al.
Publicado: (2023)

Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice
por: Kunst, Roni F., et al.
Publicado: (2022)

Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation
por: Yang, Fan, et al.
Publicado: (2016)

Correction: Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling
por: Xiao, Yongtao, et al.
Publicado: (2022)

Polygoni Multiflori Radix interferes with bile acid metabolism homeostasis by inhibiting Fxr transcription, leading to cholestasis
por: Dai, Yihang, et al.
Publicado: (2023)

Roseburia intestinalis relieves intrahepatic cholestasis of pregnancy through bile acid/FXR-FGF15 in rats
por: Sun, Hanxiang, et al.
Publicado: (2023)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile
por: Xiong, Xiao-Li, et al.
Publicado: (2019)

Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies
por: Xi, Lili, et al.
Publicado: (2023)

Real-time observation of microcirculatory leukocytes in patients undergoing major liver resection
por: Uz, Zühre, et al.
Publicado: (2021)

Impact of Global Fxr Deficiency on Experimental Acute Pancreatitis and Genetic Variation in the FXR Locus in Human Acute Pancreatitis
por: Nijmeijer, Rian M., et al.
Publicado: (2014)

Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis
por: van de Wiel, Sandra M.W., et al.
Publicado: (2022)

Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis
por: de Haan, Lianne, et al.
Publicado: (2018)

Reduced spontaneous itch in mouse models of cholestasis
por: Langedijk, Jacqueline, et al.
Publicado: (2021)

Discovery That Theonellasterol a Marine Sponge Sterol Is a Highly Selective FXR Antagonist That Protects against Liver Injury in Cholestasis
por: Renga, Barbara, et al.
Publicado: (2012)

Gut Microbes Take It to the Next Level? First Insights Into Farnesoid X Receptor Agonists of Microbial Origin
por: Lenicek, Martin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j9nhbb9867jn72foq270m3cc9b